Supportive Care and Monitoring in ICU Delirium, Agitation & Anxiety
Objective
Recommend supportive care and monitoring to manage complications associated with delirium, agitation & anxiety in the ICU.
1. Mechanical Ventilation in Agitated Patients
Mechanical ventilation may be required when severe agitation compromises airway protection, oxygenation, or ventilator synchrony. The primary goals are to ensure patient safety and gas exchange while minimizing sedation-related harms. An analgesia-first strategy is paramount.
Key Indications for Intubation
- Loss of Airway Reflexes: Inability to protect the airway, indicated by a diminished cough or gag reflex, increases aspiration risk.
- Refractory Hypoxemia: Failure to maintain adequate oxygenation despite high-flow nasal cannula or noninvasive positive pressure ventilation.
- Severe Ventilator Dyssynchrony: Patient-ventilator asynchrony that is unresponsive to sedation adjustments and compromises ventilation.
Sedation and Weaning Strategies
The goal is to use the minimum effective sedation to achieve safety and comfort, facilitating rapid liberation from the ventilator.
- Sedation Targets: Aim for light sedation (Richmond Agitation-Sedation Scale [RASS] –2 to 0), where the patient is arousable to voice. Avoid deep sedation (RASS ≤ –4), which is linked to prolonged ventilation, increased delirium, and long-term cognitive impairment.
- Weaning Considerations: Pair daily spontaneous breathing trials (SBTs) with sedation interruption. Before declaring an SBT failure, systematically address and treat pain and delirium. Dexmedetomidine is often preferred for agitated patients during weaning due to its minimal respiratory depression.
Clinical Pearl: Dexmedetomidine for Weaning
In agitated, intubated patients, an infusion of dexmedetomidine (0.2–0.7 µg/kg/h) has been shown to shorten the time to extubation compared to haloperidol. It also reduces the need for supplemental sedatives like benzodiazepines, thereby mitigating their associated risks.
Clinical Scenario
A 68-year-old intubated patient with pneumonia develops agitation (RASS +2) despite scheduled haloperidol. The team decides to switch to a dexmedetomidine infusion, titrating to maintain a RASS of –2 to 0. After 12 hours, the patient is calm, arousable, and successfully passes a spontaneous breathing trial, leading to extubation.
2. Prevention of ICU-Related Complications
Sedated and immobilized ICU patients are at high risk for venous thromboembolism (VTE), stress-related mucosal bleeding, and device-associated infections. Prophylaxis using bundled, evidence-based interventions is critical to reducing morbidity.
| Complication | Prophylaxis Strategy | Key Agents & Considerations |
|---|---|---|
| Venous Thromboembolism (VTE) | Pharmacologic prophylaxis is standard. | Use LMWH or UFH. Switch to mechanical compression (IPCs) if active bleeding or platelets < 50,000/µL. |
| Stress Ulcer Bleeding | Indicated for high-risk patients only. | High risk: mechanical ventilation >48h or coagulopathy. Use PPIs (e.g., pantoprazole 40 mg IV daily). Avoid in low-risk patients due to pneumonia risk. |
| Ventilator-Associated Pneumonia (VAP) | VAP Prevention Bundle | Elevate head-of-bed 30-45°, perform daily sedation vacations and SBTs, use oral chlorhexidine rinses, maintain endotracheal cuff pressure. |
| Central Line-Associated Bloodstream Infection (CLABSI) | CLABSI Prevention Bundle | Maximal barrier precautions on insertion, use chlorhexidine for skin prep, perform daily line necessity review, and ensure prompt removal. |
| Catheter-Associated UTI (CAUTI) | CAUTI Prevention Bundle | Avoid unnecessary catheterization, use aseptic insertion technique, maintain a closed drainage system, and ensure prompt removal. |
Clinical Pearl: Nurse-Driven Protocols
Empowering nurses to initiate and adjust VTE and sedation protocols based on clear criteria has been shown to achieve over 90% compliance, significantly lowering VTE events and reducing rates of delirium and mechanical ventilation duration.
3. Environmental and Nonpharmacologic Interventions
Optimizing the ICU environment and promoting patient engagement are powerful, low-risk strategies to mitigate delirium, reduce anxiety, and support functional recovery. These interventions form the foundation of the ABCDEF bundle.
Sleep Hygiene
- Noise and Light Control: Systematically reduce ambient noise and light, especially at night. Provide patients with earplugs and eye masks to promote restorative sleep.
- Cluster Care: Group nursing tasks, medication administration, and lab draws to create protected blocks of time for uninterrupted sleep.
Early Mobilization and Cognitive Reorientation
- Early Mobility: Initiate passive or active range-of-motion exercises within 48 hours of ICU admission, as soon as the patient is hemodynamically stable. Progress systematically to sitting, standing, and ambulation.
- Cognitive Reorientation: Encourage family presence to provide familiar social interaction. Use clocks, calendars, and personal photographs to orient the patient. Nurses should frequently reorient the patient to person, place, and time.
Clinical Pearl: The Power of Reorientation
Implementing a standardized reorientation protocol, delivered by the nursing team every 2 hours during waking hours, has been shown to reduce the prevalence of delirium by as much as 25% in at-risk ICU patients.
4. Management of Iatrogenic Complications
Pharmacotherapies used to manage agitation and delirium carry significant risks. Vigilant monitoring and proactive management are essential to prevent harm from cardiac effects, neurologic syndromes, oversedation, and withdrawal.
| Complication | Key Features / Monitoring | Management |
|---|---|---|
| QTc Prolongation | Caused by antipsychotics (hERG blockade). Monitor baseline ECG; repeat 2-4h post-dose in high-risk patients. | Discontinue or switch agent if QTc > 500 ms or increases by ≥ 60 ms. Correct electrolyte abnormalities (K+, Mg++). |
| Extrapyramidal Symptoms (EPS) | Acute dystonia, parkinsonism, or akathisia (restlessness) from dopamine blockade. | Treat with benztropine 1–2 mg IV or diphenhydramine 25–50 mg IV. Consider switching to a lower-potency agent. |
| Neuroleptic Malignant Syndrome (NMS) | Rare but life-threatening. Look for fever, severe muscle rigidity, autonomic instability, and elevated CK. | Immediately stop antipsychotic. Provide supportive care (cooling, hydration) and start dantrolene. |
| Oversedation & Withdrawal | Prolonged sedation leads to weakness. Abrupt cessation of benzodiazepines or opioids causes withdrawal. | Perform daily sedation interruptions. For withdrawal, implement a gradual taper (e.g., reduce infusion by 10-20% daily). |
Clinical Pearl: Haloperidol Dosing
The risk of Torsades de Pointes increases markedly with cumulative haloperidol doses > 20 mg/day. When required, use low, intermittent doses (e.g., 0.5–1 mg IV every 2-4 hours) and prioritize QTc monitoring.
5. Sedation and Analgesia Protocols
A structured, protocolized approach to sedation and analgesia is proven to improve outcomes. Key principles include prioritizing pain control (analgesia-first), maintaining light sedation, and performing daily awakenings to assess neurologic function and readiness for liberation.
6. Multidisciplinary Goals of Care Conversations
In the context of critical illness, it is vital to involve patients (when able), families, and the entire care team in ongoing discussions. These conversations help align intensive medical treatments with the patient’s values, preferences, and overall prognosis.
Ethical Considerations and Palliative Care
- Burdens vs. Benefits: Regularly re-evaluate the goals of invasive support. Is the current treatment plan achieving the desired outcome, or is it merely prolonging suffering?
- Palliative Care Integration: Engage palliative care specialists early, especially for patients with refractory symptoms, a high burden of therapy, or a poor prognosis. Their expertise is invaluable for managing complex symptoms and facilitating difficult conversations.
Communication Tools
Structured communication frameworks can help guide these sensitive discussions:
- SPIKES Protocol:
- Setting: Ensure a private, comfortable setting.
- Perception: Ask what the family understands about the situation.
- Invitation: Ask for permission to share information.
- Knowledge: Give information in clear, simple terms.
- Empathy: Acknowledge and validate emotions.
- Summary: Summarize the plan and check for understanding.
- Documentation: Clearly document advance directives, code status, and patient/family preferences in the medical record to ensure all team members are aware of the established goals.
Clinical Pearl: The Value of Rounds
Regular, structured interdisciplinary rounds that include the bedside nurse, physician, pharmacist, and respiratory therapist enhance communication, improve transparency, and foster consensus on daily goals of care, leading to more consistent and patient-centered treatment plans.
References
- Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
- Devlin JW, Skrobik Y, Gélinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825–e873.
- Reade MC, O’Sullivan K, Bates S, et al. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised controlled trial. Crit Care. 2009;13(3):R75.
- Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644–2653.
- Girard TD, Exline MC, Carson SS, et al. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Engl J Med. 2018;379(26):2506–2516.
- Lewis K, Al-Abdwani S, Titi L, et al. The effect of a standardized reorientation protocol on delirium in a general intensive care unit: a before-and-after study. Crit Care Med. 2025;53(3):e711–e727.
- Shehabi Y, Howe BD, Bellomo R, et al. Early Sedation with Dexmedetomidine in Critically Ill Patients. N Engl J Med. 2019;380(26):2506–2517.
